Paper42406005
Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough.
Ahuja S and 4 others. Ther Innov Regul Sci, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough. Papers, record 42406005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42406005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Repositioning | Major topic |
| Chemistry, Pharmaceutical | Major topic |
| COVID-19 Drug Treatment | Major topic |
| Humans | |
| Structure-Activity Relationship | |
| Drug Discovery | |
| Precision Medicine |
Source PubMed
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32615525 | Repurposing old drugs to fight multidrug resistant cancers. | Drug Resist Updat | 2020 | https://conductscience.org/library/papers/32615525 | PubMed |
| 2 | 33190955 | Drug Repurposing: Considerations to Surpass While Re-directing Old Compounds for New Treatments. | Arch Med Res | 2021 | https://conductscience.org/library/papers/33190955 | PubMed |
| 3 | 36477604 | DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features. | Sci Rep | 2022 | https://conductscience.org/library/papers/36477604 | PubMed |
| 4 | 34550729 | Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers. | Sci Transl Med | 2021 | https://conductscience.org/library/papers/34550729 | PubMed |
| 5 | 24239728 | Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. | Drug Discov Today | 2014 | https://conductscience.org/library/papers/24239728 | PubMed |
| 6 | 24901567 | Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks. | Nat Med | 2014 | https://conductscience.org/library/papers/24901567 | PubMed |
| 7 | 32419905 | Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs. | Comput Struct Biotechnol J | 2020 | https://conductscience.org/library/papers/32419905 | PubMed |
| 8 | 37589736 | Can nonsteroidal anti-inflammatory drugs (NSAIDs) be repurposed for fungal infection? | Naunyn Schmiedebergs Arch Pharmacol | 2024 | https://conductscience.org/library/papers/37589736 | PubMed |
| 9 | 32845283 | Efficacy of Telmisartan to Slow Growth of Small Abdominal Aortic Aneurysms: A Randomized Clinical Trial. | JAMA Cardiol | 2020 | https://conductscience.org/library/papers/32845283 | PubMed |
| 10 | 39457604 | Compared Antileishmanial Activity of Clomiphene and Tamoxifen. | Biomedicines | 2024 | https://conductscience.org/library/papers/39457604 | PubMed |
| 11 | 31238113 | Drug repurposing: a promising tool to accelerate the drug discovery process. | Drug Discov Today | 2019 | https://conductscience.org/library/papers/31238113 | PubMed |
| 12 | 33617254 | A Decade of FDA-Approved Drugs (2010-2019): Trends and Future Directions. | J Med Chem | 2021 | https://conductscience.org/library/papers/33617254 | PubMed |
| 13 | 30513339 | The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions. | Drug Discov Today | 2019 | https://conductscience.org/library/papers/30513339 | PubMed |
| 14 | 30310233 | Drug repurposing: progress, challenges and recommendations. | Nat Rev Drug Discov | 2019 | https://conductscience.org/library/papers/30310233 | PubMed |
| 15 | 35906687 | Drug repurposing: a systematic review on root causes, barriers and facilitators. | BMC Health Serv Res | 2022 | https://conductscience.org/library/papers/35906687 | PubMed |
| 16 | 28369768 | Drug repurposing from the perspective of pharmaceutical companies. | Br J Pharmacol | 2018 | https://conductscience.org/library/papers/28369768 | PubMed |
| 17 | 29874824 | Changing Trends in Computational Drug Repositioning. | Pharmaceuticals (Basel) | 2018 | https://conductscience.org/library/papers/29874824 | PubMed |
| 18 | 30123072 | Review of Drug Repositioning Approaches and Resources. | Int J Biol Sci | 2018 | https://conductscience.org/library/papers/30123072 | PubMed |
| 19 | 33431024 | A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions. | J Cheminform | 2020 | https://conductscience.org/library/papers/33431024 | PubMed |
| 20 | 40608229 | Drug repurposing: a promising drug discovery strategy for the treatment of emerging epidemic infectious disease. | Mol Divers | 2026 | https://conductscience.org/library/papers/40608229 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42406005
GET https://conductscience.org/api/papers/v1/42406005/references?page=2